SEI Investments
GNMK

SEI Investments’s GenMark Diagnostics, Inc GNMK Stock Holding History

SEI Investments’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-44,163
Closed -$650K – 2542
2020
Q2 		$650K Buy
+44,163
New +$449K ﹤0.01% 1741
2018
Q3 		– Sell
-359
Closed -$2K – 3659
2018
Q2 		$2K Buy
+359
New +$2.37K ﹤0.01% 3407

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

SEI Investments's GNMK Position: Q3 2020 in Review

SEI Investments sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2020, closing a stake of 44,163 shares — an estimated $650K sold.

SEI Investments first reported a position in GNMK in Q2 2018 and held it in 2 quarters. The position peaked at $650K in Q2 2020. 163 funds tracked by Wall St. Rank hold GNMK as of Q3 2020.

  • SEI Investments reported no remaining GenMark Diagnostics, Inc position as of Q3 2020 after selling out during the quarter.
  • SEI Investments sold 44,163 GenMark Diagnostics, Inc shares in Q3 2020, an estimated $650K.
  • SEI Investments first reported a position in GenMark Diagnostics, Inc in Q2 2018 and held it in 2 quarters.
  • SEI Investments's GenMark Diagnostics, Inc position peaked at $650K in Q2 2020.
  • 163 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2020.

Based on SEI Investments's 13F filing for Q3 2020, filed 6 Nov 2020.